Sopharma’s 2022 net profit down by 15%

Leading pharmaceuticals manufacturer and distributor Sopharma posted a slowdown in terms of net profit, down by 15% YoY to BGN 77.9M. This is mainly due to acquisition of and exemption from subsidiaries in the amount of BGN 36.1 million, as well as the accrued 2022 impairments of non-current assets in the amount of BGN 20.8 million.